These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3952128)

  • 1. A primate model for the study of hallucinogens.
    Schlemmer RF; Davis JM
    Pharmacol Biochem Behav; 1986 Feb; 24(2):381-92. PubMed ID: 3952128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational determination of dose-response curves in hallucinogen-treated monkeys.
    Brewster JM; Siegel RK; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(2):102-8. PubMed ID: 820666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of specificity of an animal behavior model for hallucinogenic drug action.
    White FJ; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1981 Mar; 14(3):339-43. PubMed ID: 7232460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute and chronic effect of 5-methoxytryptamine on selected members of a primate social colony.
    Heinze WJ; Schlemmer RF; Williams EA; Davis JM
    Biol Psychiatry; 1980 Dec; 15(6):829-39. PubMed ID: 6936054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.
    Schlemmer RF; Narasimhachari N; Thompson VD; Davis JM
    Commun Psychopharmacol; 1977; 1(2):105-18. PubMed ID: 414877
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
    Benneyworth MA; Smith RL; Sanders-Bush E
    Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
    Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
    J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 11. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
    Trulson ME; Preussler DW; Trulson VM
    J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 14. Human psychopharmacology of N,N-dimethyltryptamine.
    Strassman RJ
    Behav Brain Res; 1996; 73(1-2):121-4. PubMed ID: 8788488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.
    Yamamoto T; Ueki S
    Pharmacol Biochem Behav; 1981 Jan; 14(1):89-95. PubMed ID: 6258178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Hallucinogens on Unconditioned Behavior.
    Halberstadt AL; Geyer MA
    Curr Top Behav Neurosci; 2018; 36():159-199. PubMed ID: 28224459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.
    Riga MS; Bortolozzi A; Campa L; Artigas F; Celada P
    Neuropharmacology; 2016 Feb; 101():370-8. PubMed ID: 26477571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.
    Kyzar EJ; Collins C; Gaikwad S; Green J; Roth A; Monnig L; El-Ounsi M; Davis A; Freeman A; Capezio N; Stewart AM; Kalueff AV
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):194-202. PubMed ID: 22251567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hallucinogens on blind monkeys.
    Siegel RK; Brewster JM; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.